Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao-Qing-Long-Tang)" on airway inflammation in a mouse model.
暂无分享,去创建一个
[1] F. Levi-Schaffer,et al. New insights on the involvement of Nerve Growth Factor in allergic inflammation and fibrosis. , 2003, Cytokine & growth factor reviews.
[2] A. Ishige,et al. Possible involvement of suppression of Th2 differentiation in the anti-allergic effect of Sho-seiryu-to in mice. , 2002, Japanese journal of pharmacology.
[3] G. Pauli,et al. Nerve growth factor levels and localisation in human asthmatic bronchi , 2002, European Respiratory Journal.
[4] G. Hoyle,et al. Augmentation of allergic early-phase reaction by nerve growth factor. , 2002, American journal of respiratory and critical care medicine.
[5] H. Kiyohara,et al. Pinellic acid from the tuber of Pinellia ternata Breitenbach as an effective oral adjuvant for nasal influenza vaccine. , 2002, International immunopharmacology.
[6] H. Kita,et al. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. , 2002, Blood.
[7] S. Kao,et al. Effects of xiao‐qing‐long‐tang (XQLT) on bronchoconstriction and airway eosinophil infiltration in ovalbumin‐sensitized guinea pigs: in vivo and in vitro studies , 2001, Allergy.
[8] N. Frossard,et al. Nerve growth factor secretion by human lung epithelial A549 cells in pro- and anti-inflammatory conditions. , 2001, European journal of pharmacology.
[9] P. Barnes,et al. Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases. , 2001, European journal of pharmacology.
[10] N. Frossard,et al. Human lung fibroblasts secrete nerve growth factor: effect of inflammatory cytokines and glucocorticoids. , 2001, The European respiratory journal.
[11] F. Levi-Schaffer,et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblasts, demonstrating a direct role for this factor in tissue repair , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Kao,et al. The effect of Chinese herbal medicine, xiao‐qing‐long tang (XQLT), on allergen‐induced bronchial inflammation in mite‐sensitized mice , 2000, Allergy.
[13] A. Togias,et al. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. , 2000, American journal of respiratory and critical care medicine.
[14] T. Ochi,et al. Effects of Sho-seiryu-to (Xiao-Qing-Long-Tang) on experimental allergic reactions. , 2000 .
[15] Y. Sakakura,et al. Effects of Sho-seiryu-to on experimental allergic rhinitis in guinea pigs. , 1999, Methods and findings in experimental and clinical pharmacology.
[16] W. Luttmann,et al. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. , 1998, American journal of respiratory and critical care medicine.
[17] R. Paus,et al. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma , 1998, European journal of immunology.
[18] H. Yamada,et al. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "sho-seiryu-to"--stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice. , 1998, Immunopharmacology and immunotoxicology.
[19] A. Ishige,et al. Further pharmacological study on Sho-seiryu-to as an antiallergic. , 1997, Methods and findings in experimental and clinical pharmacology.
[20] S. Bonini,et al. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[21] L. Nencioni,et al. Nerve Growth Factor Is an Autocrine Survival Factor for Memory B Lymphocytes , 1996, Cell.
[22] K. Feingold,et al. β-Nerve Growth Factor as a Mediator of the Acute Phase Responsein Vivo☆ , 1996 .
[23] M. Marinaro,et al. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. , 1995, Journal of immunology.
[24] H. Nagai,et al. Time course study for antigen-induced airway hyperreactivity and the effect of soluble IL-5 receptor. , 1995, Life sciences.
[25] S. Durham,et al. Phenotype of cells positive for interleukin-4 and interleukin-5 mRNA in allergic tissue reactions. , 1995, International archives of allergy and immunology.
[26] S. Umland,et al. Mechanisms of allergic pulmonary eosinophilia in the mouse. , 1994, The Journal of allergy and clinical immunology.
[27] R. Egan,et al. Characterization of a murine model of allergic pulmonary inflammation. , 1994, International archives of allergy and immunology.
[28] A. Buriani,et al. Mast cells synthesize, store, and release nerve growth factor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Johnson,et al. Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate-early gene induction. , 1994, The Journal of biological chemistry.
[30] P. Erb,et al. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[31] S. Durham,et al. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. , 1993, The Journal of allergy and clinical immunology.
[32] E. Gelfand,et al. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. , 1992, The Journal of allergy and clinical immunology.
[33] F. Levi-Schaffer,et al. Mast cells enhance migration and proliferation of fibroblasts into an in vitro wound. , 1990, Experimental cell research.
[34] C. Bronner,et al. Activation of rat peritoneal mast cells by substance P and mastoparan. , 1989, The Journal of pharmacology and experimental therapeutics.
[35] S. Tamura,et al. Measurement of antigen-specific mouse IgE by a fluorometric reverse (IgE-capture) ELISA. , 1989, Journal of immunological methods.
[36] Y. Nishimura,et al. [A comparison between Chinese blended medicine "shoseiryuto", tranilast and ketotifen on the anti-allergic action in the guinea pigs]. , 1985, Arerugi = [Allergy].
[37] Y. Nakamura,et al. [Asthmatic children and Chinese medicine. Scientific study of shoseiryuto and saibokuto]. , 1984, Arerugi = [Allergy].
[38] H. Fujimura,et al. [Biologically active principles of crude drugs. Anti-allergic principles of "Shoseiryu-to." I. Effect on delayed-type allergy reaction]. , 1982, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.
[39] K. Kawamoto,et al. Nerve growth factor and wound healing. , 2004, Progress in brain research.
[40] D. Robinson. Th-2 cytokines in allergic disease. , 2000, British medical bulletin.
[41] Y. Ohmoto,et al. The herbal medicine shoseiryu-to inhibits allergen-induced synthesis of tumour necrosis factor alpha by peripheral blood mononuclear cells in patients with perennial allergic rhinitis. , 1998, Acta oto-laryngologica. Supplementum.
[42] A. Ishige,et al. Pharmacological characteristics of Sho-seiryu-to, an antiallergic Kampo medicine without effects on histamine H1 receptors and muscarinic cholinergic system in the brain. , 1996, Methods and findings in experimental and clinical pharmacology.
[43] T. Takasaka,et al. Inhibitory effects of sho-seiryu-to on acetylcholine-induced responses in nasal gland acinar cells. , 1994, The American journal of Chinese medicine.
[44] T. Takishima,et al. Modulation of human basophil growth in vitro by xiao-qing-long-tang (syo-seiryu-to), chai-pu-tang (saiboku-to), qing-fei-tang (seihai-to), baicalein and ketotifen. , 1989, The American journal of Chinese medicine.
[45] R. Coffman,et al. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.
[46] E. Hosoya,et al. Recent Advances in the Pharmacology of KAMPO (JAPANESE HERBAL) MEDICINES , 1988 .